(Butylamino)acetonitrile → (RS)-N-butyl-4-chloro-N-(cyanomethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide

HRID 930985

Reaktionsgleichung

Reaktionsgleichung von HRID 930985
[Cl:1][C:2]1[C:3]2[C:10]3[CH2:11][CH2:12][CH:13]([C:15]([OH:17])=O)[CH2:14][C:9]=3[S:8][C:4]=2[N:5]=[CH:6][N:7]=1.[CH2:18]([NH:22][CH2:23][C:24]#[N:25])[CH2:19][CH2:20][CH3:21]>>[CH2:18]([N:22]([CH2:23][C:24]#[N:25])[C:15]([CH:13]1[CH2:12][CH2:11][C:10]2[C:3]3[C:2]([Cl:1])=[N:7][CH:6]=[N:5][C:4]=3[S:8][C:9]=2[CH2:14]1)=[O:17])[CH2:19][CH2:20][CH3:21]

Komponenten

3

Edukt 2

HCID 76373(Butylamino)acetonitrileHCID 17990077HCID 17990077, Verbindung

Produkt 1

HCID 90015777(RS)-N-butyl-4-chloro-N-(cyanomethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide

Versuchsvorschrift

300 mg (1.12 mmol) (RS)-4-chloro-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxylic acid (prepared according to intermediate example 31b) were transformed in analogy to example 3 using (butylamino)acetonitrile to give after working up and purification 280 mg (69%) of the title compound.

Aufarbeitung

  1. customto give
  2. custompurification 280 mg (69%) of the title compound

Quellen und Nachweise

ORD-Eintrag
ord-9388160c06b84dc1a83c39fb4d8b83b9
Quelldatensatz
uspto-grants-2016_03
Patentnummer
US09296757B2

Verknüpfte Notizen

Wird geladen…